Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30

$12.95−0.45 (-3.36%)

Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –

Pharming statistics

83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Dec 31, 2025
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $908.68M; $280.48M
Enterprise Value: $763.37M; $148.62M
PE Ratio: 323.75; 24.95
PS Ratio: 2.42; 3.60
P/FCF Ratio: 16.84; 18.26
P/OCF Ratio: 16.61; 12.93

Enterprise valuationIndustry

EV / Sales: 2.03; 2.60
EV / EBITDA: 29.54; 16.52
EV / EBIT: 29.54; 18.72
EV / FCF: 14.15; 22.07

Share statisticsIndustry

Shares Outstanding: 702M; 58M
Shares Change (YoY): -4.91%; 10.9%
Float: 702M; 49M
Shares Held by Insiders: 0.00%; 12.1%
Shares Held by Institutions: 0.32%; 56.4%

Short sellingIndustry

Short Interest: 25,783; –
Short Interest Change: 92.0%; -0.76%
Days to Cover: 1.42; 5.13

Stock price statisticsIndustry

52-Week High: $21.34; –
52-Week Low: $9.11; –
20-Day Moving Average: $11.78; –
50-Day Moving Average: $10.94; –
200-Day Moving Average: $13.49; –
Average True Range (14): $0.54; –
Price Change (1 Week): 5.28%; 1.51%
Price Change (1 Month): 34.3%; -2.37%
Price Change (3 Months): 10.5%; -21.1%
Price Change (6 Months): -0.08%; -22.8%
Price Change (YTD): -26.7%; -22.6%
Price Change (1 Year): -18.0%; -21.0%
Price Change (3 Years): 18.8%; -24.8%
Price Change (5 Years): 43.1%; -76.9%
Average Volume (10 Days): 15,743; –
Average Volume (20 Days): 17,426; –
Average Volume (90 Days): 20,745; –
Relative Volume: 0.61; 0.80
Relative Strength Index (14): 64.9; 44.7
Volatility (1 Year): 60.4%; 80.2%
Beta (5 Years): 0.55; 1.07

MarginsIndustry

Gross Margin: 87.9%; 53.0%
Operating Margin: 6.87%; -38.5%
Pretax Margin: 3.42%; -11.8%
Profit Margin: 0.76%; -31.7%
EBITDA Margin: 6.87%; -27.7%
FCF Margin: 14.3%; -8.85%

Returns on capitalIndustry

Return on Assets (ROA): 0.63%; -40.7%
Return on Capital Employed (ROCE): 6.73%; -38.1%

Financial positionIndustry

Current Ratio: 2.59; 3.31
Quick Ratio: 1.73; 2.41
Interest Coverage: 131.85; -6.35

GrowthIndustry

Revenue Growth (YoY): 26.6%; 7.26%
Revenue Growth (3Y CAGR): 22.3%; 2.25%
Revenue Growth (5Y CAGR): 12.1%; 6.41%
EPS Growth (3Y CAGR): -40.5%; -0.17%
EPS Growth (5Y CAGR): -40.8%; 3.77%

EfficiencyIndustry

Asset Turnover: 0.84; 0.40
Inventory Turnover: 0.75; 2.73
Revenue Per Employee: $7.52K; $429.38K
Profits Per Employee: $57; -$683.67K
Employee Count: 50,000; 75
WACC: 7.64%; 10.0%

Income statement (TTM)Industry

Revenue: $376.13M; $66.69M
Gross Profit: $330.63M; $116.10M
Operating Income: $25.84M; -$20.99M
Pretax Income: $12.85M; -$13.23M
Net Income: $2.85M; -$21.61M
EBITDA: $25.84M; -$16.85M
EPS (Diluted): $0.00; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $145.31M; $67.18M
Net Cash (Debt): $145.31M; $16.98M
Net Cash Per Share: $0.21; $0.72
Working Capital: $183.68M; $78.52M

Cash flow (TTM)Industry

Operating Cash Flow: $54.71M; -$12.27M
Capital Expenditures: -$749.00K; -$944.00K
Free Cash Flow: $53.96M; -$18.20M
FCF Per Share: $0.08; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 0.31%; -21.0%
FCF Yield: 5.94%; -9.44%

Taxes and interestIndustry

Interest Expense: $196.00K; $2.97M
Income Tax: $10.31M; $74.00K
Effective Tax Rate: 80.3%; 20.9%

Scores and fair valueIndustry

Altman Z-Score: 3.05; 0.26
Piotroski F-Score: 7; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	PHAR	S&P 500	Difference	PHAR per year	S&P 500 per year
1 month	+34.8%	-2.7%	+37.5 pts
3 months	+9.5%	-1.7%	+11.2 pts
Year to date	-26.7%	+11.9%	−38.6 pts
1 year	-24.5%	+12.0%	−36.5 pts
3 years	+17.6%	+78.2%	−60.6 pts	+5.6%	+21.2%
5 years	+43.1%	+73.2%	−30.1 pts	+7.4%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PHAR shares were sold short on Oct 30, 2026, up 92.0% from the previous report. At recent volumes it would take 1.4 days to buy them back. Over the last 20 sessions, 46.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	25,783	+92.0%	18,220	1.4
Oct 15, 2026	13,429	-33.2%	9,137	1.5
Sep 30, 2026	20,097	-3.8%	52,636	1.0
Sep 15, 2026	20,882	-16.6%	17,185	1.2
Aug 31, 2026	25,053	-65.5%	17,420	1.4
Aug 14, 2026	72,693	+279.0%	29,943	2.4
Jul 31, 2026	19,179	+93.0%	9,696	2.0
Jul 15, 2026	9,938	+210.4%	6,876	1.4
Jun 30, 2026	3,202	-23.4%	5,842	1.0
Jun 15, 2026	4,178	-14.6%	8,247	1.0
May 29, 2026	4,895	-8.6%	13,967	1.0
May 15, 2026	5,355	-34.8%	17,525	1.0